Firefly Neuroscience (AIFF) Other Operating Expenses (2021 - 2025)

Firefly Neuroscience has reported Other Operating Expenses over the past 5 years, most recently at -$20.1 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at -$20.1 million for Q4 2025, down 87.02% from a year ago — trailing twelve months through Dec 2025 was -$24.4 million (down 56.88% YoY), and the annual figure for FY2025 was -$20.1 million, down 87.02%.
  • Other Operating Expenses for Q4 2025 was -$20.1 million at Firefly Neuroscience, down from -$2.6 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for AIFF hit a ceiling of $1.4 million in Q2 2023 and a floor of -$20.1 million in Q4 2025.
  • Median Other Operating Expenses over the past 5 years was -$842963.0 (2021), compared with a mean of -$3.0 million.
  • Biggest five-year swings in Other Operating Expenses: plummeted 535.3% in 2024 and later skyrocketed 3140.38% in 2025.
  • Firefly Neuroscience's Other Operating Expenses stood at -$883502.0 in 2021, then tumbled by 432.03% to -$4.7 million in 2022, then skyrocketed by 121.27% to $1.0 million in 2023, then plummeted by 1175.2% to -$10.8 million in 2024, then crashed by 87.02% to -$20.1 million in 2025.
  • The last three reported values for Other Operating Expenses were -$20.1 million (Q4 2025), -$2.6 million (Q3 2025), and -$1.9 million (Q2 2025) per Business Quant data.